Search Results 1241-1250 of 13318 for monoclonal antibody

1. Rovalpituzumab Tesirine In Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   ... monoclonal antibodies): 2 weeks. Immune-checkpoint inhibitors (e.g., anti-PD-1, anti-PD-L1, or anti-CTLA-4), monoclonal antibodies, antibody-drug conjugates ...

2. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

3. Integration, innovation, precision: Propelling leading-edge diagnostics - Mayo Clinic News Network

   At present, of the 30-plus antibodies the neuroimmunology lab has tests for, more than five are only available at Mayo Clinic Laboratories because they are new ...

4. A Study Of Idasanutlin In Combination With Obinutuzumab In Relapsed/Refractory (R/R) Follicular Lymphoma (FL) And In Combination With Rituximab In R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

   ... monoclonal antibody (mAb) and for which no other more appropriate treatment option exists; At least one bidimensionally measurable lesion; Agreement to remain ...

5. A Study To Assess Change In Disease Activity And Adverse Events (AE)s In Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) As An Intravenous (IV) Infusion - Mayo Clinic

   * Has previously been exposed to a proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody. Exclusion Criteria: * Known history of clinically ...

6. Study In Pediatrics With HypEREosinophilic Syndrome - Mayo Clinic

   Participants who have received any other monoclonal antibodies ... Participants with any history of hypersensitivity to any monoclonal antibody (including ...

7. Study To Evaluate The Efficacy And Safety Of MEDI9929 (AMG 157) In Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

   ... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...

8. A Phase 1-2 Dose-Escalation And Cohort-Expansion Study Of Oral EFT508 In Subjects With Hematological Malignancies - Mayo Clinic

   Part 2 (Cohort Expansion): Subjects must have received adequate prior therapy including at a minimum including at a minimum anti-CD20 monoclonal antibody ...

9. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

10. A Study of CMB305 and Atezolizumab in Patients with Sarcoma - Mayo Clinic

    ... monoclonal antibodies, fusion proteins, or CHO cell products. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...